IBDEI2K8 ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,43438,1,4,0)
 ;;=4^I72.4
 ;;^UTILITY(U,$J,358.3,43438,2)
 ;;=^269777
 ;;^UTILITY(U,$J,358.3,43439,0)
 ;;=I72.0^^167^2078^35
 ;;^UTILITY(U,$J,358.3,43439,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43439,1,3,0)
 ;;=3^Aneurysm of Carotid Artery
 ;;^UTILITY(U,$J,358.3,43439,1,4,0)
 ;;=4^I72.0
 ;;^UTILITY(U,$J,358.3,43439,2)
 ;;=^5007793
 ;;^UTILITY(U,$J,358.3,43440,0)
 ;;=I73.00^^167^2078^141
 ;;^UTILITY(U,$J,358.3,43440,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43440,1,3,0)
 ;;=3^Raynaud's Syndrome w/o Gangrene
 ;;^UTILITY(U,$J,358.3,43440,1,4,0)
 ;;=4^I73.00
 ;;^UTILITY(U,$J,358.3,43440,2)
 ;;=^5007796
 ;;^UTILITY(U,$J,358.3,43441,0)
 ;;=I73.9^^167^2078^131
 ;;^UTILITY(U,$J,358.3,43441,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43441,1,3,0)
 ;;=3^Peripheral Vascular Disease,Unspec
 ;;^UTILITY(U,$J,358.3,43441,1,4,0)
 ;;=4^I73.9
 ;;^UTILITY(U,$J,358.3,43441,2)
 ;;=^184182
 ;;^UTILITY(U,$J,358.3,43442,0)
 ;;=I74.2^^167^2078^106
 ;;^UTILITY(U,$J,358.3,43442,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43442,1,3,0)
 ;;=3^Embolism & Thrombosis UE Arteries
 ;;^UTILITY(U,$J,358.3,43442,1,4,0)
 ;;=4^I74.2
 ;;^UTILITY(U,$J,358.3,43442,2)
 ;;=^5007801
 ;;^UTILITY(U,$J,358.3,43443,0)
 ;;=I74.3^^167^2078^105
 ;;^UTILITY(U,$J,358.3,43443,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43443,1,3,0)
 ;;=3^Embolism & Thrombosis LE Arteries
 ;;^UTILITY(U,$J,358.3,43443,1,4,0)
 ;;=4^I74.3
 ;;^UTILITY(U,$J,358.3,43443,2)
 ;;=^5007802
 ;;^UTILITY(U,$J,358.3,43444,0)
 ;;=I80.11^^167^2078^138
 ;;^UTILITY(U,$J,358.3,43444,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43444,1,3,0)
 ;;=3^Phleb & Thrombphleb Rt Femoral Vein
 ;;^UTILITY(U,$J,358.3,43444,1,4,0)
 ;;=4^I80.11
 ;;^UTILITY(U,$J,358.3,43444,2)
 ;;=^5007825
 ;;^UTILITY(U,$J,358.3,43445,0)
 ;;=I80.211^^167^2078^139
 ;;^UTILITY(U,$J,358.3,43445,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43445,1,3,0)
 ;;=3^Phleb & Thrombphleb Rt Iliac Vein
 ;;^UTILITY(U,$J,358.3,43445,1,4,0)
 ;;=4^I80.211
 ;;^UTILITY(U,$J,358.3,43445,2)
 ;;=^5007831
 ;;^UTILITY(U,$J,358.3,43446,0)
 ;;=I80.12^^167^2078^135
 ;;^UTILITY(U,$J,358.3,43446,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43446,1,3,0)
 ;;=3^Phleb & Thrombphleb Lt Femoral Vein
 ;;^UTILITY(U,$J,358.3,43446,1,4,0)
 ;;=4^I80.12
 ;;^UTILITY(U,$J,358.3,43446,2)
 ;;=^5007826
 ;;^UTILITY(U,$J,358.3,43447,0)
 ;;=I80.13^^167^2078^132
 ;;^UTILITY(U,$J,358.3,43447,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43447,1,3,0)
 ;;=3^Phleb & Thrombphleb Bil Femoral Vein
 ;;^UTILITY(U,$J,358.3,43447,1,4,0)
 ;;=4^I80.13
 ;;^UTILITY(U,$J,358.3,43447,2)
 ;;=^5007827
 ;;^UTILITY(U,$J,358.3,43448,0)
 ;;=I80.202^^167^2078^137
 ;;^UTILITY(U,$J,358.3,43448,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43448,1,3,0)
 ;;=3^Phleb & Thrombphleb Lt LE Deep Vessels
 ;;^UTILITY(U,$J,358.3,43448,1,4,0)
 ;;=4^I80.202
 ;;^UTILITY(U,$J,358.3,43448,2)
 ;;=^5007829
 ;;^UTILITY(U,$J,358.3,43449,0)
 ;;=I80.201^^167^2078^140
 ;;^UTILITY(U,$J,358.3,43449,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43449,1,3,0)
 ;;=3^Phleb & Thrombphleb Rt LE Deep Vessels
 ;;^UTILITY(U,$J,358.3,43449,1,4,0)
 ;;=4^I80.201
 ;;^UTILITY(U,$J,358.3,43449,2)
 ;;=^5007828
 ;;^UTILITY(U,$J,358.3,43450,0)
 ;;=I80.203^^167^2078^134
 ;;^UTILITY(U,$J,358.3,43450,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43450,1,3,0)
 ;;=3^Phleb & Thrombphleb Bil LE Deep Vessels
 ;;^UTILITY(U,$J,358.3,43450,1,4,0)
 ;;=4^I80.203
 ;;^UTILITY(U,$J,358.3,43450,2)
 ;;=^5007830
 ;;^UTILITY(U,$J,358.3,43451,0)
 ;;=I80.212^^167^2078^136
 ;;^UTILITY(U,$J,358.3,43451,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43451,1,3,0)
 ;;=3^Phleb & Thrombphleb Lt Iliac Vein
